Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

TDP-43 Proteinopathies MeSH Descriptor Data 2026


MeSH Heading
TDP-43 Proteinopathies
Tree Number(s)
C10.574.950
C18.452.845.800
Unique ID
D057177
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D057177
Scope Note
Diseases characterized by the presence of abnormally phosphorylated, ubiquitinated, and cleaved DNA-binding protein TDP-43 in affected brain and spinal cord. Inclusions of the pathologic protein in neurons and glia, without the presence of AMYLOID, is the major feature of these conditions, thus making these proteinopathies distinct from most other neurogenerative disorders in which protein misfolding leads to brain amyloidosis. Both frontotemporal lobar degeneration and AMYOTROPHIC LATERAL SCLEROSIS exhibit this common method of pathogenesis and thus they may represent two extremes of a continuous clinicopathological spectrum of one disease.
Entry Term(s)
TDP-43-Mediated Neurodegeneration
Public MeSH Note
2010
History Note
2010
Date Introduced
2010/01/01
Last Updated
2026/01/01
TDP-43 Proteinopathies Preferred
TDP-43-Mediated Neurodegeneration Narrower
page delivered in 0.15s